GLP-1 receptor agonists can dial down inflammation in the brain, raising hopes for treating neurodegenerative diseases Medha Baranwal26 Feb 2024 11:45 PM ISTUSA: Evidence suggests that glucagon-like peptide 1 (GLP-1) receptor agonists that reduce obesity can reduce inflammation in the kidneys, liver and...
Short-acting GLP-1 receptor agonists may increase risk of GERD in patients with type 2 diabetes: Study Medha Baranwal17 Jan 2024 1:30 AM ISTUSA: A large international propensity score-matched database study has revealed an association between starting shorter-acting glucagon-like peptide-1...
SGLT-2 inhibitors promising option for CVD prevention in diabetes patients regardless of NAFLD status: JAMA Medha Baranwal3 Jan 2024 9:00 AM ISTSouth Korea: A recent study published in JAMA Network Open has highlighted the potential of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) as a...
Use of GLP-1 drugs in type 2 diabetes tied to reduced risk of colorectal cancer: JAMA Medha Baranwal9 Dec 2023 11:30 AM ISTUSA: A nationwide cohort study revealed a greater reduction in the risk of colorectal cancer (CRC) with the use of glucagon-like peptide 1 (GLP-1)...
GLP1RAs treatment may improve reproductive health in obese PCOS patients Medha Baranwal29 Nov 2023 10:00 AM ISTChina: A meta-analysis and systematic review have shed light on the effects of Glucagon-like peptide 1 receptor agonists (GLP1RAs) on menstrual...
Novel GLP-1R agonist beinaglutide exhibits favourable hypoglycemic effect in patients with type 2 diabetes Medha Baranwal24 Oct 2023 11:00 AM ISTChina: A multicenter, open-label, randomized trial has shown that a new GLP-1RA, beinaglutide, exhibits a favourable hypoglycemic effect on patients...
SGLT2 inhibitors have similar fracture risk as other antidiabetics in postmenopausal women with diabetes: JAMA Medha Baranwal3 Oct 2023 11:15 AM ISTSouth Korea: A claims-based study involving two independent Korean cohorts revealed that SGLT2 inhibitors are associated with a lower or similar risk...
GLP-1RA Therapy Effective in Combating Knee Osteoarthritis in T2D Patients Jacinthlyn Sylvia27 July 2023 11:00 AM ISTObesity has long been known as a risk factor for the development and progression of knee osteoarthritis (KOA). However, a recent research from the...
Are GLP1-Agonists best out of new diabetes medications for primary CVD prevention? Medha Baranwal10 May 2023 11:00 AM ISTUSA: Among diabetes patients already on insulin, metformin, or sulfonylurea treatment and without cardiovascular disease, the addition of GLP-1...
Glucagon-like peptide-1 receptor agonists improve kidney graft survival following kidney transplantation Aditi26 April 2023 8:00 PM ISTJapan: In a study published in The Journal of Clinical Endocrinology & Metabolism, JCEM, researchers have addressed the crucial role of GLP-1 RAs...
GLP1 RA use tied to increased risk of rapidly worsening retinopathy in type 2 diabetes Medha Baranwal2 Aug 2022 10:00 AM ISTUSA: Glucagon-like peptide-1 receptor agonists (GLP1 RA) are significantly associated with an increased risk of diabetic retinopathy (DR) with...
GLP-1 Receptor Agonists up Risk of Gallbladder and Biliary Disease MD Bureau30 March 2022 11:00 AM ISTGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) are recommended for patients with type 2 diabetes to control glycemia and reduce cardiovascular...
